{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:00:53Z","timestamp":1791986453394,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"am","delay-in-days":383,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21TR001734"],"award-info":[{"award-number":["R21TR001734"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GMCA175803"],"award-info":[{"award-number":["R01GMCA175803"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.bcp.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T12:30:20Z","timestamp":1508502620000},"page":"174-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Drug resistance induces the upregulation of H2S-producing enzymes in HCT116 colon cancer cells"],"prefix":"10.1016","volume":"149","author":[{"given":"Ashley A.","family":"Untereiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Pavlidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadiya","family":"Druzhyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Papapetropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2017.10.007_b0005","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.3390\/ijms18010197","article-title":"Colorectal carcinoma: a general overview and future perspectives in colorectal cancer","volume":"18","author":"M\u00e1rmol","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2017.10.007_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03195243","article-title":"Aberrant epigenetic patterns in the etiology of gastrointestinal cancers","volume":"49","author":"Karpinski","year":"2008","journal-title":"J. Appl. Gen."},{"key":"10.1016\/j.bcp.2017.10.007_b0015","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2017.10.007_b0020","first-page":"1531","article-title":"Molecular basis of 5-fluorouracil-related toxicity: lessons from clinical practice","volume":"34","author":"Papanastasopoulos","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bcp.2017.10.007_b0025","first-page":"2168","article-title":"Cell cycle-mediated drug resistance: an emerging concept in cancer therapy","volume":"7","author":"Shah","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2017.10.007_b0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2017.10.007_b0035","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1073\/pnas.1306241110","article-title":"Tumor-derived hydrogen sulfide, produced by cystathionine-beta-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer","volume":"110","author":"Szabo","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2017.10.007_b0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.niox.2014.03.001","article-title":"Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-\u03b2-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro","volume":"41","author":"M\u00f3dis","year":"2014","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bcp.2017.10.007_b0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2119\/molmed.2016.00102","article-title":"Cystathionine-\u03b2-synthase inhibition for colon cancer: Enhancement of the efficacy of aminooxyacetic acid via the prodrug approach","volume":"22","author":"Chao","year":"2016","journal-title":"Mol. Med."},{"key":"10.1016\/j.bcp.2017.10.007_b0050","doi-asserted-by":"crossref","first-page":"e79167","DOI":"10.1371\/journal.pone.0079167","article-title":"Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance","volume":"8","author":"Bhattacharyya","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bcp.2017.10.007_b0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2015.05.024","article-title":"Role of cystathionine \u03b2-synthase in human breast Cancer","volume":"86","author":"Sen","year":"2015","journal-title":"Free Rad. Biol. Med."},{"key":"10.1016\/j.bcp.2017.10.007_b0060","doi-asserted-by":"crossref","first-page":"36125","DOI":"10.1038\/srep36125","article-title":"Inhibition of hydrogen sulfide biosynthesis sensitizes lung adenocarcinoma to chemotherapeutic drugs by inhibiting mitochondrial DNA repair and suppressing cellular bioenergetics","volume":"6","author":"Szczesny","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2017.10.007_b0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd.2015.1","article-title":"Gasotransmitters in cancer: from pathophysiology to experimental therapy","volume":"15","author":"Szabo","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2017.10.007_b0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1096\/fj.12-216507","article-title":"Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics","volume":"27","author":"Modis","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2017.10.007_b0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/bs.mie.2014.11.042","article-title":"Oxidation of H2S in mammalian cells and mitochondria","volume":"554","author":"Abou-Hamdan","year":"2015","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bcp.2017.10.007_b0080","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1096\/fj.06-7407com","article-title":"Sulfide, the first inorganic substrate for human cells","volume":"21","author":"Goubern","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2017.10.007_b0085","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bcp.2013.08.064","article-title":"Hydrogen sulfide-mediated stimulation of mitochondrial electron transport involves inhibition of the mitochondrial phosphodiesterase 2A, elevation of cAMP and activation of protein kinase A","volume":"86","author":"M\u00f3dis","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2017.10.007_b0090","doi-asserted-by":"crossref","first-page":"13829","DOI":"10.1073\/pnas.1105121108","article-title":"Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function","volume":"108","author":"Suzuki","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2017.10.007_b0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/SHK.0000000000000478","article-title":"AP39, a mitochondrially targeted hydrogen sulfide donor, exerts protective effects in renal epithelial cells subjected to oxidative stress in vitro and in acute renal injury in vivo","volume":"45","author":"Ahmad","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.bcp.2017.10.007_b0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.niox.2014.04.008","article-title":"AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro","volume":"41","author":"Szczesny","year":"2014","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bcp.2017.10.007_b0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.phrs.2016.08.023","article-title":"S-sulfhydration of ATP synthase by hydrogen sulfide stimulates mitochondrial bioenergetics","volume":"113","author":"Modis","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2017.10.007_b0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcp.2017.03.025","article-title":"H2S-induced S-sulfhydration of lactate dehydrogenase a (LDHA) stimulates cellular bioenergetics in HCT116 colon cancer cells","volume":"136","author":"Untereiner","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2017.10.007_b0115","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/bph.12369","article-title":"Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms","volume":"171","author":"Szabo","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2017.10.007_b0120","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1111\/bph.12368","article-title":"Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects","volume":"171","author":"Modis","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2017.10.007_b0125","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/jb\/mvp111","article-title":"Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide","volume":"146","author":"Shibuya","year":"2009","journal-title":"J. Biochem."},{"key":"10.1016\/j.bcp.2017.10.007_b0130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bbrc.2013.02.131","article-title":"Oxidative stress suppresses the cellular bioenergetic effect of the 3-mercaptopyruvate sulfurtransferase\/hydrogen sulfide pathway","volume":"433","author":"Modis","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2017.10.007_b0135","first-page":"171","article-title":"Hydrogen sulfide generation from l-cysteine in the human glioblastoma-astrocytoma U-87 MG and neuroblastoma SHSY5Y cell lines","volume":"64","author":"Bronowicka-Adamska","year":"2017","journal-title":"Acta Biochim. Pol."},{"issue":"166","key":"10.1016\/j.bcp.2017.10.007_b0140","first-page":"e15","article-title":"Expression profile of hydrogen sulfide and its synthases correlates with tumor stage and grade in urothelial cell carcinoma of bladder","volume":"34","author":"Gai","year":"2016","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.bcp.2017.10.007_b0145","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bcp.2011.12.014","article-title":"Cellular bioenergetics is regulated by PARP1 under resting conditions and during oxidative stress","volume":"83","author":"M\u00f3dis","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2017.10.007_b0150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.drudis.2007.12.010","article-title":"The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox)","volume":"13","author":"Szak\u00e1cs","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2017.10.007_b0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2017.10.007_b0160","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/bcr2154","article-title":"Targeting aspartate aminotransferase in breast cancer","volume":"10","author":"Thornburg","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bcp.2017.10.007_b0165","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2017.10.007_b0170","first-page":"4409","article-title":"Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro","volume":"6","author":"Ikeda","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2017.10.007_b0175","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1124\/dmd.107.015354","article-title":"Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17","volume":"35","author":"Shen","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2017.10.007_b0180","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/bph.12171","article-title":"Selectivity of commonly used pharmacological inhibitors for cystathionine \u03b2 synthase (CBS) and cystathionine \u03b3 lyase (CSE)","volume":"169","author":"Asimakopoulou","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2017.10.007_b0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2016.08.016","volume":"113","author":"Druzhyna","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2017.10.007_b0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ccr.2012.07.016","article-title":"Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells","volume":"22","author":"Domingo-Domenech","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2017.10.007_b0195","doi-asserted-by":"crossref","first-page":"41706","DOI":"10.18632\/oncotarget.5991","article-title":"5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits","volume":"6","author":"Denise","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2017.10.007_b0200","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/ars.2014.5933","article-title":"The therapeutic potential of cystathionine beta-synthetase\/hydrogen sulfide inhibition in cancer","volume":"22","author":"Hellmich","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2017.10.007_b0205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.yexcr.2014.09.027","article-title":"Dedifferentiation of cancer cells following recovery from a potentially lethal damage is mediated by H2S-Nampt","volume":"330","author":"Ostrakhovitch","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2017.10.007_b0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/gut.50.2.201","article-title":"Mucosal protection against sulphide: importance of the enzyme rhodanese","volume":"50","author":"Picton","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2017.10.007_b0215","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/BJ20110841","article-title":"Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide","volume":"439","author":"Mikami","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2017.10.007_b0220","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00806085","article-title":"L-Cysteine metabolism via 3-mercaptopyruvate pathway and sulfate formation in rat liver mitochondria","volume":"2","author":"Ubuka","year":"1992","journal-title":"Amino Acids"},{"key":"10.1016\/j.bcp.2017.10.007_b0225","doi-asserted-by":"crossref","first-page":"14774","DOI":"10.1038\/srep14774","article-title":"Identification of H2S3 and H2S produced by 3-mercaptopyruvate sulfurtransferase in the brain","volume":"5","author":"Kimura","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2017.10.007_b0230","first-page":"S1611","article-title":"Rhodanese activity of resting, regenerating, and neoplastic liver tissue of the rat","volume":"15","author":"Rosenthal","year":"1955","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bcp.2017.10.007_b0235","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0305-0491(92)90276-W","article-title":"Rhodanese and ALA-S in mammary tumor and liver from normal and tumor-bearing mice","volume":"102","author":"Navone","year":"1992","journal-title":"Comp. Biochem. Physiol. B"},{"key":"10.1016\/j.bcp.2017.10.007_b0240","doi-asserted-by":"crossref","first-page":"G288","DOI":"10.1152\/ajpgi.00324.2005","article-title":"Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation","volume":"291","author":"Ramasamy","year":"2006","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"10.1016\/j.bcp.2017.10.007_b0245","doi-asserted-by":"crossref","first-page":"e37572","DOI":"10.1371\/journal.pone.0037572","article-title":"Hydrogen sulfide lowers proliferation and induces protective autophagy in colon epithelial cells","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2017.10.007_b0250","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1600-0765.2007.00999.x","article-title":"Hydrogen sulfide inhibits cell proliferation and induces cell cycle arrest via an elevated p21 Cip1 level in Ca9-22 cells","volume":"43","author":"Takeuchi","year":"2008","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.bcp.2017.10.007_b0255","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3892\/etm.2011.244","article-title":"Trifluorothymidine exhibits potent antitumor activity via the induction of DNA double-strand breaks","volume":"2","author":"Suzuki","year":"2011","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bcp.2017.10.007_b0260","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2012.08.034","article-title":"ATM and LKB1 dependent activation of AMPK sensitizes cancer cells to etoposide-induced apoptosis","volume":"328","author":"Luo","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2017.10.007_b0265","doi-asserted-by":"crossref","first-page":"53272","DOI":"10.1074\/jbc.M406879200","article-title":"Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species","volume":"279","author":"Kurz","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2017.10.007_b0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.niox.2016.06.005","article-title":"Stimulatory effect of CSE-generated H2S on hepatic mitochondrial biogenesis and the underlying mechanisms","volume":"58","author":"Untereiner","year":"2016","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bcp.2017.10.007_b0275","first-page":"7","article-title":"Cancer Statistics","volume":"67","author":"Siegel","year":"2017","journal-title":"Cancer"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217306378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217306378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:01:20Z","timestamp":1757768480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295217306378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":55,"alternative-id":["S0006295217306378"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2017.10.007","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug resistance induces the upregulation of H2S-producing enzymes in HCT116 colon cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}